<DOC>
	<DOCNO>NCT00347425</DOCNO>
	<brief_summary>The study evaluate safety tolerability switch subject schizophrenia schizoaffective disorder exist antipsychotic medication Bifeprunox .</brief_summary>
	<brief_title>Switch Study Existing Atypical Antipsychotics Bifeprunox</brief_title>
	<detailed_description />
	<mesh_term>Schizophrenia</mesh_term>
	<mesh_term>Psychotic Disorders</mesh_term>
	<mesh_term>Ziprasidone</mesh_term>
	<mesh_term>Risperidone</mesh_term>
	<mesh_term>Antipsychotic Agents</mesh_term>
	<mesh_term>Aripiprazole</mesh_term>
	<mesh_term>Quetiapine Fumarate</mesh_term>
	<mesh_term>Olanzapine</mesh_term>
	<criteria>Males female , 1865 year , meet DSMIV TR diagnosis Schizophrenia Schizoaffective Disorder switch indicate Acutely psychotic current Axis I primary psychiatric diagnosis schizophrenia schizoaffective disorder base DSMIV TR criterion</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>May 2008</verification_date>
	<keyword>Switch Study</keyword>
	<keyword>Schizophrenia</keyword>
	<keyword>Atypical Antipsychotics</keyword>
</DOC>